185 related articles for article (PubMed ID: 32401173)
1.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
[TBL] [Abstract][Full Text] [Related]
2. Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Oncol Rep; 2021 Mar; 45(3):1295-1305. PubMed ID: 33469680
[TBL] [Abstract][Full Text] [Related]
3. RAD52 gene polymorphisms are associated with risk of colorectal cancer in a Chinese Han population.
Zhang L; Zhang Y; Tang CH; Su CM
Medicine (Baltimore); 2017 Dec; 96(49):e8994. PubMed ID: 29245274
[TBL] [Abstract][Full Text] [Related]
4. Contribution of XPD and XPF Polymorphisms to Susceptibility of Non-Small Cell Lung Cancer in High-Altitude Areas.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Li G
Public Health Genomics; 2021; 24(3-4):189-198. PubMed ID: 33827099
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 genetic variants are associated with susceptibility of non-small cell lung cancer in a Shaanxi Han population.
Jia Z; Zhou W; Zhang G; Fu J; Li D; Ren L
Genomics; 2020 Sep; 112(5):3465-3472. PubMed ID: 32464168
[TBL] [Abstract][Full Text] [Related]
6. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
[TBL] [Abstract][Full Text] [Related]
7. [Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients].
Li HM; Yuan P; Yu DK; Ma F; Tan WW; Feng T; Yang J; Huang Y; Lin DX; Xu BH; Tan W
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):504-9. PubMed ID: 27531263
[TBL] [Abstract][Full Text] [Related]
8. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.
Lu C; Chen YD; Han S; Wei J; Ge Y; Pan W; Jiang T; Qiu XG; Yang M
J Neurooncol; 2014 Oct; 120(1):11-7. PubMed ID: 25012956
[TBL] [Abstract][Full Text] [Related]
9. IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population.
Li Y; Zhao W; Zhao Z; Wu J; Chen L; Ma Y; Li Q; Lu D; Jin L; Wang J
Lung Cancer; 2015 Sep; 89(3):232-7. PubMed ID: 26141218
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.
Qin H; Zhu J; Zeng Y; Du W; Shen D; Lei Z; Qian Q; Huang JA; Liu Z
Oncotarget; 2017 Jan; 8(5):8330-8341. PubMed ID: 28039450
[TBL] [Abstract][Full Text] [Related]
11. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.
Yin JY; Meng XG; Qian CY; Li XP; Chen J; Zheng Y; Liu R; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2015 Mar; 36(3):375-84. PubMed ID: 25732572
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
[TBL] [Abstract][Full Text] [Related]
13. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
[TBL] [Abstract][Full Text] [Related]
14. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.
Liu Y; Bi Y; Lin J; Cao L; He B; Zhang Z; Cui Y; Zhang X
Tumour Biol; 2015 Mar; 36(3):1955-62. PubMed ID: 25394898
[TBL] [Abstract][Full Text] [Related]
15. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
[TBL] [Abstract][Full Text] [Related]
16. Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.
Wang Y; Zhang Y; Gu C; Bao W; Bao Y
Med Oncol; 2014 May; 31(5):932. PubMed ID: 24676996
[TBL] [Abstract][Full Text] [Related]
17. The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.
Liu W; Ma Q; Li C; Li Y; Liu S; Shi L; Yao Y
Hum Immunol; 2021 Dec; 82(12):917-922. PubMed ID: 34373132
[TBL] [Abstract][Full Text] [Related]
18. XAB2 tagSNPs contribute to non-small cell lung cancer susceptibility in Chinese population.
Pei N; Cao L; Liu Y; Wu J; Song Q; Zhang Z; Yuan J; Zhang X
BMC Cancer; 2015 Jul; 15():560. PubMed ID: 26228655
[TBL] [Abstract][Full Text] [Related]
19. Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
Du Y; He Y; Mei Z; Qian L; Shi J; Jie Z
Clin Respir J; 2016 May; 10(3):311-7. PubMed ID: 25308691
[TBL] [Abstract][Full Text] [Related]
20. Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population.
Han S; Gao F; Yang W; Ren Y; Liang X; Xiong X; Pan W; Zhou L; Zhou C; Ma F; Yang M
Int J Clin Exp Med; 2015; 8(9):16528-35. PubMed ID: 26629180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
